Comprehension of the adapted Urticaria Activity Score measure and patient guidance document: qualitative interviews with adults and adolescents with chronic spontaneous urticaria
Itch and hives are important symptoms of CSU. Results support the content validity of an adapted UAS as a daily measure of severity of itch and hives and provided valuable suggestions for improving its patient guidance, which can be used in future clinical trials involving adults and adolescents ≥ 12 years old with CSU to assess the severity of itch and hives.
Authors
- Julie McLaren
- Mariana Ştefan (ORCID: https://orcid.org/0000-0001-5272-4770)
- Pallavi B. Rane
- Olabimpe Ruth Eseyin
- Anne Skalicky (ORCID: https://orcid.org/0000-0001-9865-3824)
- Marcus Maurer (ORCID: https://orcid.org/0000-0002-4121-481X)
- Yan Wang (ORCID: https://orcid.org/0009-0002-2584-9337)
Institutions
- Ithaka Harbors (US)
- Amgen (United States) (US)
- Humboldt-Universität zu Berlin (DE)
- Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1186/s41687-024-00830-9
- Primary Topic
- Urticaria and Related Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- AstraZeneca